Yunkai Yang
Hangzhou Medical College(CN)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Vaccine Coverage and Hesitancy, Epigenetics and DNA Methylation, Ferroptosis and cancer prognosis
Most-Cited Works
- → Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial(2020)1,207 cited
- → Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults(2021)828 cited
- → Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes(2020)803 cited
- → Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial(2021)198 cited
- → The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy(2022)120 cited
- → RUNX2 recruits the NuRD(MTA1)/CRL4B complex to promote breast cancer progression and bone metastasis(2022)71 cited
- → Improving benefit-cost analysis to overcome financing difficulties in promoting energy-efficient renovation of existing residential buildings in China(2014)57 cited
- → Role of Epigenetic Regulation in Plasticity of Tumor Immune Microenvironment(2021)53 cited
- → Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco(2022)51 cited
- → SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis(2021)51 cited